Stock Quote
NeoStem, Inc. (NBS) (American Stock Exchange)
$1.66
2:58pm EST
-3.49%
$1.72
$1.74
13,149
$1.74
$1.59
$2.72
$0.41
-0.16
28,168
No news stories for this company within the last 30 days.
NBS
More News
| Press Releases
| Key Developments
| Name | Current Position | Compensation |
|---|---|---|
| Smith, Robin | Chairman of the Board, Chief Executive Officer | 773,028 |
| May, Lawrence | Chief Financial Officer | 183,294 |
| Vaczy, Catherine | Vice President, General Counsel | 418,978 |
Profile
NeoStem, Inc. (NeoStem) is engaged in a platform business of operating a commercial autologous (donor and recipient are the same) adult stem cell bank and in pre-disease collection, processing and long-term storage of stem cells from adult donors that they can access for their own future medical... Full Description
Company Address
NeoStem, Inc.
Suite 450,
420 Lexington Avenue,
New York NY 10170
P: +1212.5844180
Suite 450,
420 Lexington Avenue,
New York NY 10170
P: +1212.5844180
Analyst Research
Performance of Key Competitors
| Company | Price | Change |
|---|---|---|
| PerkinElmer, Inc. | $19.13 | +0.09 |
| CRYO-CELL International, Inc. | $1.82 | 0.00 |
| NBS | Industry | |
|---|---|---|
| P/E(TTM) | -- | 10.45 |
| P/S(TTM) | 108.03 | 1.18 |
| ROI(TTM) | -165.23 | 4.30 |
| ROE(TTM) | -404.16 | 8.83 |
No consensus estimates data available.
| Total Revenue | $0.03M |
| Net Income | $-4.69M |
| EPS | $-0.62 |
